A5113076038University of Debrecen
2023-2025
Abstract Aims Classifying patients as responders or non‐responders to cardiac resynchronization therapy (CRT) has been recently challenged, suggesting that preventing heart failure (HF) progression may also provide survival benefits. We assessed a novel classification based on echocardiographic left ventricular (LV) reverse remodelling and the occurrence of acute HF hospitalization (HHF) sustained arrhythmia (VA) within 1‐year post‐CRT. Methods results Patients implanted with CRT...
Background: Non-responders to Cardiac Resynchronization Therapy (CRT-NR) have poor prognosis. Sacubitril/valsartan (SV) treatment improved the outcomes of heart failure patients with reduced left ventricular (LV) ejection fraction (HFrEF) in randomized trials; however, limited data are available on specific cohort CRT-NRs. Aim study: We compared hospitalization (HFH) and mortality rates three patient cohorts: CRT-NR S/V versus ACEi/ARB general HFrEF S/V. Methods: 275 HF patients, including...